These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 3120871)
1. Aluminium and human albumin solutions. Cuthbertson B; McBay WE; Welch AG; Perry RJ; Foster PR Br Med J (Clin Res Ed); 1987 Oct; 295(6605):1062. PubMed ID: 3120871 [No Abstract] [Full Text] [Related]
2. Time-dependent increase of aluminium in human albumin solutions: the role of initial citrate content. Menditto A; Sardelli R; Lanzieri G; Orlando M Vox Sang; 2001 Feb; 80(2):121. PubMed ID: 11378967 [No Abstract] [Full Text] [Related]
3. [The quality of our drugs: aluminum in plasma components]. Forth W Klin Wochenschr; 1989 Dec; 67(24):1219-20. PubMed ID: 2698978 [No Abstract] [Full Text] [Related]
4. Aluminum contamination of albumin-replacement solutions. Loeliger EA; de Wolff FA N Engl J Med; 1985 May; 312(21):1389-90. PubMed ID: 3990741 [No Abstract] [Full Text] [Related]
5. Inadvertent aluminum administration during plasma exchange due to aluminum contamination of albumin-replacement solutions. Milliner DS; Shinaberger JH; Shuman P; Coburn JW N Engl J Med; 1985 Jan; 312(3):165-7. PubMed ID: 3965935 [No Abstract] [Full Text] [Related]
6. Aluminium and nickel in human albumin solutions. Gammelgaard B; Sandberg E J Trace Elem Electrolytes Health Dis; 1989 Mar; 3(1):39-42. PubMed ID: 2535318 [TBL] [Abstract][Full Text] [Related]
7. Reduction of aluminium concentration in albumin products. Inoue M; Gion Y; Itoh H; Ikariya K; Takechi K; Morimoto K; Tomioka S; Furuta K; Yabushita S Vox Sang; 1994; 66(4):249-52. PubMed ID: 8079447 [TBL] [Abstract][Full Text] [Related]
8. UV-C irradiation of human albumin solution on manufacturing scale. MacLeod AJ Dev Biol (Basel); 2004; 118():139-47. PubMed ID: 15645684 [No Abstract] [Full Text] [Related]
9. Aluminium bone disease. el Habib R; Eygonnet JP Br Med J (Clin Res Ed); 1987 Nov; 295(6610):1415-6. PubMed ID: 3121039 [No Abstract] [Full Text] [Related]
10. [Problems in the production of human albumin solutions]. Fürst G; Stöcker U; Dengler T Beitr Infusionsther; 1989; 24():83-90. PubMed ID: 2481553 [TBL] [Abstract][Full Text] [Related]
12. [Effect of affinity medium and solution conditions on endotoxin removal from protein solutions]. Xing H; Huang Y; Li Y; Luo J; Zhang L; Ma G; Su Z Sheng Wu Gong Cheng Xue Bao; 2010 Nov; 26(11):1584-95. PubMed ID: 21284220 [TBL] [Abstract][Full Text] [Related]
13. Aluminium loading in premature infants during intensive care as related to clinical aspects. von Stockhausen HB; Schrod L; Brätter P; Rösick U J Trace Elem Electrolytes Health Dis; 1990 Dec; 4(4):209-13. PubMed ID: 2136283 [TBL] [Abstract][Full Text] [Related]
14. Cutaneous reactions to aluminium in vaccines: an avoidable problem. Cox NH; Moss C; Forsyth A Lancet; 1988 Jul; 2(8601):43. PubMed ID: 2898644 [No Abstract] [Full Text] [Related]
15. The removal of model viruses, poliovirus type 1 and canine parvovirus, during the purification of human albumin using ion-exchange chromatographic procedures. Cameron R; Davies J; Adcock W; MacGregor A; Barford JP; Cossart Y; Harbour C Biologicals; 1997 Dec; 25(4):391-401. PubMed ID: 9467035 [TBL] [Abstract][Full Text] [Related]